Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Romiplostim N01”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)WithdrawnNCT07532408
What this trial is testing

Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345000
What this trial is testing

Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Treatment-naïve Severe Aplastic Anemia
Qilu Pharmaceutical Co., Ltd. 210
Not applicableNot Yet RecruitingNCT07214025
What this trial is testing

Safety and Efficacy of Romiplostim in Treatment of Chronic ITP in Children

Who this might be right for
Romiplostim N01ITP
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT06686927
What this trial is testing

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

Who this might be right for
Primary Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128576
What this trial is testing

Romiplostim N01 for the Treatment of Thrombocytopenia Associated With Radiotherapy-Combined Treatment Regimens in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Zhujiang Hospital 60
Large-scale testing (Phase 3)UnknownNCT06440824
What this trial is testing

Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Who this might be right for
CTIT-Chemotherapy Induced Thrombocytopenia
Shandong University 60
Not applicableLooking for participantsNCT07206823
What this trial is testing

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

Who this might be right for
Primacy Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07063225
What this trial is testing

Romiplostim N01 for Chemotherapy-induced Thrombocytopenia

Who this might be right for
Chemotherapy-induced ThrombocytopeniaRomiplostim N01
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)UnknownNCT06658834
What this trial is testing

Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 129
Testing effectiveness (Phase 2)Looking for participantsNCT06898983
What this trial is testing

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Who this might be right for
Cancer Treatment-induced Thrombocytopenia (CTIT)
Anhui Provincial Hospital 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07572084
What this trial is testing

Romiplostim N01 in Chemoradiotherapy-induced Aplastic Anemia

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07558434
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 43
Not applicableNot Yet RecruitingNCT07162519
What this trial is testing

Romiplostim N01 in the Treatment of Thrombocytopenia Caused by Cytotoxic Drugs in Breast Cancer Patients

Who this might be right for
Cytotoxic DrugsRomiplostim N01Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 68
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07829952
What this trial is testing

Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Henan University of Science and Technology 87
Early research (Phase 1)Not Yet RecruitingNCT07595133
What this trial is testing

Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia

Who this might be right for
Sepsis
Shanghai 10th People's Hospital 280
Next Page